Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in
   previously untreated HER2 positive locally advanced or metastastic
   esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA
   trial (AIO STO 0217)

Dokumenttyp:: Meeting Abstract
Autor(en):: Goekkurt, E.; Binder, M.; Lorenzen, S.; Thuss-Patience, P. C.; Al-Batran, S-E.; Hinke, A.; Hegewisch-Becker, S.; Nilsson, S.; Bokemeyer, C.; Stein, A.
Titel:: Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217)
Zeitschriftentitel:: Ann Oncol
Jahr:: 2018
Band / Volume:: 29
Print-ISSN:: 0923-7534
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: